PharmEasy’s valuation drops despite raising over $200 million for a 2025 IPO…阅读更多(Read More) 文章导航 China’s EVs expected to nearly double global sales in 2025 IPO-bound co-working firm IndiQube’s FY24 loss rises by 72%